305 related articles for article (PubMed ID: 28425223)
1. Three families with mild PMM2-CDG and normal cognitive development.
Vals MA; Morava E; Teeäär K; Zordania R; Pajusalu S; Lefeber DJ; Õunap K
Am J Med Genet A; 2017 Jun; 173(6):1620-1624. PubMed ID: 28425223
[TBL] [Abstract][Full Text] [Related]
2. A nationwide survey of PMM2-CDG in Italy: high frequency of a mild neurological variant associated with the L32R mutation.
Barone R; Carrozzi M; Parini R; Battini R; Martinelli D; Elia M; Spada M; Lilliu F; Ciana G; Burlina A; Leuzzi V; Leoni M; Sturiale L; Matthijs G; Jaeken J; Di Rocco M; Garozzo D; Fiumara A
J Neurol; 2015 Jan; 262(1):154-64. PubMed ID: 25355454
[TBL] [Abstract][Full Text] [Related]
3. Genotypes and estimated prevalence of phosphomannomutase 2 deficiency in Turkey differ significantly from those in Europe.
Yıldız Y; Arslan M; Çelik G; Kasapkara ÇS; Ceylaner S; Dursun A; Sivri HS; Coşkun T; Tokatlı A
Am J Med Genet A; 2020 Apr; 182(4):705-712. PubMed ID: 31981409
[TBL] [Abstract][Full Text] [Related]
4. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.
Serrano M; de Diego V; Muchart J; Cuadras D; Felipe A; Macaya A; Velázquez R; Poo MP; Fons C; O'Callaghan MM; García-Cazorla A; Boix C; Robles B; Carratalá F; Girós M; Briones P; Gort L; Artuch R; Pérez-Cerdá C; Jaeken J; Pérez B; Pérez-Dueñas B
Orphanet J Rare Dis; 2015 Oct; 10():138. PubMed ID: 26502900
[TBL] [Abstract][Full Text] [Related]
5. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
[TBL] [Abstract][Full Text] [Related]
6. PMM2-CDG: phenotype and genotype in four affected family members.
Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
[TBL] [Abstract][Full Text] [Related]
7. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
[TBL] [Abstract][Full Text] [Related]
8. From gestalt to gene: early predictive dysmorphic features of PMM2-CDG.
Martinez-Monseny A; Cuadras D; Bolasell M; Muchart J; Arjona C; Borregan M; Algrabli A; Montero R; Artuch R; Velázquez-Fragua R; Macaya A; Pérez-Cerdá C; Pérez-Dueñas B; Pérez B; Serrano M;
J Med Genet; 2019 Apr; 56(4):236-245. PubMed ID: 30464053
[TBL] [Abstract][Full Text] [Related]
9. Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of glycosylation Ia).
Casado M; O'Callaghan MM; Montero R; Pérez-Cerda C; Pérez B; Briones P; Quintana E; Muchart J; Aracil A; Pineda M; Artuch R
Cerebellum; 2012 Jun; 11(2):557-63. PubMed ID: 22012410
[TBL] [Abstract][Full Text] [Related]
10. Renal involvement in PMM2-CDG, a mini-review.
Altassan R; Witters P; Saifudeen Z; Quelhas D; Jaeken J; Levtchenko E; Cassiman D; Morava E
Mol Genet Metab; 2018 Mar; 123(3):292-296. PubMed ID: 29229467
[TBL] [Abstract][Full Text] [Related]
11. Clinical and whole-exome sequencing findings in two siblings from Hani ethnic minority with congenital glycosylation disorders.
Zhang Z; Huang TL; Ma J; He WJ; Gu H
BMC Med Genet; 2019 Nov; 20(1):181. PubMed ID: 31727010
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and genetic analysis for two children with congenital disturbance of glycosylation with PMM2 gene mutations].
Ren C; Fang F; Huang Y; Cheng H; Dai L
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):938-42. PubMed ID: 26887550
[TBL] [Abstract][Full Text] [Related]
13. The Analysis of Variants in the General Population Reveals That
Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
[TBL] [Abstract][Full Text] [Related]
14. Clinical and radiological correlates of activities of daily living in cerebellar atrophy caused by PMM2 mutations (PMM2-CDG).
Pettinato F; Mostile G; Battini R; Martinelli D; Madeo A; Biamino E; Frattini D; Garozzo D; Gasperini S; Parini R; Sirchia F; Sortino G; Sturiale L; Matthijs G; Morrone A; Di Rocco M; Rizzo R; Jaeken J; Fiumara A; Barone R
Cerebellum; 2021 Aug; 20(4):596-605. PubMed ID: 33619652
[TBL] [Abstract][Full Text] [Related]
15. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.
Monin ML; Mignot C; De Lonlay P; Héron B; Masurel A; Mathieu-Dramard M; Lenaerts C; Thauvin C; Gérard M; Roze E; Jacquette A; Charles P; de Baracé C; Drouin-Garraud V; Khau Van Kien P; Cormier-Daire V; Mayer M; Ogier H; Brice A; Seta N; Héron D
Orphanet J Rare Dis; 2014 Dec; 9():207. PubMed ID: 25497157
[TBL] [Abstract][Full Text] [Related]
16. Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.
Thompson DA; Lyons RJ; Russell-Eggitt I; Liasis A; Jägle H; Grünewald S
J Inherit Metab Dis; 2013 Nov; 36(6):1039-47. PubMed ID: 23430200
[TBL] [Abstract][Full Text] [Related]
17. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
[TBL] [Abstract][Full Text] [Related]
18. Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies.
Chong M; Yoon G; Susan-Resiga D; Chamberland A; Cheillan D; Paré G; Seidah NG
J Med Genet; 2020 Jan; 57(1):11-17. PubMed ID: 31391289
[TBL] [Abstract][Full Text] [Related]
19. Genotype-Phenotype Correlations in PMM2-CDG.
Vaes L; Rymen D; Cassiman D; Ligezka A; Vanhoutvin N; Quelhas D; Morava E; Witters P
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828263
[TBL] [Abstract][Full Text] [Related]
20. Primary ovarian insufficiency in a female with phosphomannomutase-2 gene (PMM2) mutations for congenital disorder of glycosylation.
Masunaga Y; Mochizuki M; Kadoya M; Wada Y; Okamoto N; Fukami M; Kato F; Saitsu H; Ogata T
Endocr J; 2021 May; 68(5):605-611. PubMed ID: 33583911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
